TPO gene mutations associated with thyroid carcinoma: Case report and literature review
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The thyroperoxidase (TPO) genetic variants in thyroid carcinoma is scarcely reported. OBJECTIVE: We report on a pedigree of thyroid papillary carcinoma and hypoechoic thyroid nodules with the TPO gene mutations. METHODS: The compound heterozygotic mutations of the TPO gene (c.2268-2269 insT and c.2090 G>A) in two patients with congenital goiters hypothyroidism were demonstrated. Fifteen family members of the proband and 105 control individuals were enrolled. The participants underwent clinical examination and molecular screening for TPO mutation. The hypoechoic thyroid nodules underwent fine needle aspiration biopsy. RESULTS: The mutation c.2268-2269 insT was detected in the four family members with normal thyroid hormone levels. The other two members harbored the c.2090 G>A mutation. The heterozygotes had degeneratively hypoechoic thyroid nodules. The control individuals showed no mutation. The maternal grandfather developed a multifocal papillary thyroid carcinoma with lymph gland and nerve invasion in the left lobe of the thyroid gland. The maternal grandfather harbored the TPO c.2268-2269 insT mutation but without BRAFV600E mutation. Malignant cells were not observed in other members by fine needle aspiration biopsy. CONCLUSION: TPO genetic variants may be associated with thyroid carcinoma and hypoechoic thyroid nodules in a few cases. Long-term follow-up in the pedigree with congenital goiter is reasonable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Children and adolescents with primary CH due to dyshormonogenesis (mainly TPO gene, but also SLC5A5/NIS, SLC26A4/PDS, DUOX, and TG gene mutations) may have an increased risk of developing goiter and thyroid nodules, and may even have an increased risk of malignancy.”
From Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update—An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology (2021) · cites this paper as [180]
Experimental — accuracy not yet measuredIn the citing paper
“However, to date only a few cases of thyroid cancer (either papillary or follicular) have been reported in patients with long-standing CH.”
In the citing paper
“In some cases, goiter was already present and thyroid nodules (isolated or multiple) developed despite apparently adequate LT4 treatment.”
In the citing paper
“In other cases, poor compliance to treatment, with persistently high TSH levels during adolescence, was the probable cause (179–182).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kimura, S., Kotani, T., McBride, O. W., Umeki, K., Hirai, K., Nakayama, T., & Ohtaki, S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5555 · Cited by 282 · cited 1×
“The human thyroid peroxidase (TPO) gene is located on the chromosome 2p25 and consists of 17 exons and codes 933 amino acids [1,2].”
Genetics and phenomics of hypothyroidism and goiter due to TPO mutations
Ris‐Stalpers, C., & Bikker, H. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.008 · Cited by 150
BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid Cancer
Kim, S., Lee, K. E., Myong, J., Park, J. H., Jeon, Y. K., Min, H. S., Park, S. Y., Jung, K. C., Koo, D. H., & Youn, Y. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1383-1 · Cited by 150
Kimura, S., Hong, Y. S., Kotani, T., Ohtaki, S., & Kikkawa, F. (1989) · Biochemistry · doi:10.1021/bi00436a054 · Cited by 146
Clinical Genetics of Congenital Hypothyroidism
Szinnai, G. (2014) · Endocrine Development · doi:10.1159/000363156 · Cited by 115 · cited 1×
“mal recessive manner [3,4].”
High Incidence of Thyroid Cancer in Long-Standing Goiters with Thyroglobulin Mutations
Hishinuma, A., Fukata, S., Kakudo, K., Murata, Y., & Ieiri, T. (2005) · Thyroid · doi:10.1089/thy.2005.15.1079 · Cited by 85 · cited 1×
“Goiter resulting from thyroglobulin mutations and Pendred’s syndrome gene are associated with thyroid cancer [14,15].”
Dyshormonogenetic goiter: A clinicopathologic study of 56 cases
Ghossein, R. A., Rosaí, J., & Heffess, C. S. (1997) · Endocrine Pathology · doi:10.1007/bf02739930 · Cited by 76
Higher TSH level is a risk factor for differentiated thyroid cancer
Kim, H. K., Yoon, J. H., Kim, S. J., Cho, J. S., Kweon, S., & Kang, H. (2012) · Clinical Endocrinology · doi:10.1111/cen.12027 · Cited by 74 · cited 1×
“In experimental studies, after prolonged exposure of transplanted thyroid tissue to excessive amounts of TSH in mice, the thyroid tissue was eventually transformed into malignant thyroid neoplasms [12, 13].”
Alzahrani, A. S., Baitei, E. Y., Zou, M., & Shi, Y. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2302 · Cited by 63 · cited 1×
“To date, few data suggest that TPO mutations may be implicated in PTC or nodules in the family members [6,7,10].”
Medeiros-Neto, G., Gil-da-Costa, M. J., Santos, C. L. S., Medina, A. M., Costa e Silva, J., Tsou, R. M., & Sobrinho-Simões, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5264 · Cited by 63 · cited 2×
“[6] reported a newborn with a very large congenital goiter that was found to contain a malignancy, from which lung and bone metastasis developed.”
Cited by
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
Genetic analyses in a cohort of Portuguese pediatric patients with congenital hypothyroidism
Silva, R. S., Rosário, M., Grangeia, A., Costa, C., Castro-Correia, C., Alonso, I. D. C. M. P., Leão, M., & Fontoura, M. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0047 · Cited by 29
Congenital hypothyroidism and thyroid cancer
Penna, G., Rubio, I. G. S., Brust, E. S., Cazarin, J., Hecht, F., Alkmim, N. R., Rajão, K. M. A. B., & Ramos, H. E. (2021) · Endocrine Related Cancer · doi:10.1530/erc-21-0159 · Cited by 23
“DTC cases in patients with TPO mutations were described (Medeiros-Neto et al. 1998, Chertok Shacham et al. 2012, Zhu et al. 2015).”
Lee, S. H., Lee, H. G., Yang, E. M., & Kim, C. J. (2023) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2244260.130 · Cited by 9
“27) However, with time, goiter appeared and an elevated TSH level was reported.”
BackgroundYu, Y., Bovenhuis, H., Wu, Z., Laport, K., Groenen, M. A. M., & Crooijmans, R. P. M. A. (2021) · Genes · doi:10.3390/genes12070997 · Cited by 11
“The association between TPO gene mutations including intronic variants and missense variants and thyroid carcinoma was also seen in humans [55,56].”
Backgroundvan Trotsenburg, A. S. P., Stoupa, A., Léger, J., Rohrer, T. R., Peters, C. J., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.3.8 · Cited by 9
Molina, M. F., Pio, M. G., Scheps, K. G., Adrover, E., Abelleyro, M. M., Targovnik, H. M., & Rivolta, C. M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111748 · Cited by 7
Long-Term Outcome of Patients with TPO Mutations
Tobias, L., Elias-Assad, G., Khayat, M., Admoni, O., Almashanu, S., & Tenenbaum‐Rakover, Y. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173898 · Cited by 8
“This case was previously reported by our group [18] and it joins few other reports of follicular carcinoma in patients with TPO mutations [19,20].”
ResultVincenzi, G., Petralia, I. T., Abbate, M. T. A., Tarantola, G., Meroni, S. L. C., Maggiore, R., Mari, G., Patricelli, M. G., Lena, M. S., Barera, G., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1205785 · Cited by 5
Chen, P., Li, Z., Hong, Z., Zheng, H., & Zeng, R. (2023) · Biophysics Reports · doi:10.52601/bpr.2023.230005 · Cited by 4
Clinical Relevance of Molecular Diagnosis in Patients with Congenital Hypothyroidism
Nicola, J. P. (2017) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000240 · Cited by 5
“Significantly, levothyroxine therapy in patients with thyroid dyshormonogenesis should be carefully monitored in order to reduce TSH levels below the normal range to prevent the risk of developing thyroid cancer within the goiter in adulthood [43,44].”
BackgroundTanda, M. L. (2021) · Encyclopedia of pathology · doi:10.1007/978-3-319-28845-1_5291-1
Tanda, M. L. (2022) · Encyclopedia of pathology · doi:10.1007/978-3-030-62345-6_5291
Thyroid Peroxidase Gene Mutations Associated with Thyroid Disorders
Zubkov, A. V., & Бутова, Л. Г. (2026) · Biochemistry (Moscow) · doi:10.1134/s0006297925604265
“Further analysis of 219 patients with CH from northwestern China identified TPO mutations in 17 individuals, including two mutations affecting the intracellular domain (Pro883Ser and Gly889Arg) [24].”
InfluentialGarzón, V. F., Marti, J. L., Pio, M. G., Lazzati, J. M., ZAPPA, J., Silva, W., Dujovne, N., Rivolta, C. M., & Targovnik, H. M. (2026) · Endocrine · doi:10.1007/s12020-026-04746-w
“To date, only a limited number of cases have been reported in association with variants in the TG [59, 64–66], TPO [67–69], SLC5A5 (encodes the sodium-iodide symporter, NIS) [70], SLC26A4 (encode pen-drin) [71–73], and DUOX2 [74] genes.”
Metadata
- Authors
- Zhu, H., Peng, Y.-G., Ma, S.-G., & Liu, H.
- Affiliations
- Nanjing Drum Tower Hospital (CN)
- Department of Endocrinology and Metabolism, Huai'an Hospital Affiliated to Xuzhou Medical College and Huai'an Second People's Hospital, Huai'an, Jiangsu, China
- Xuzhou Medical College (CN)
- Corresponding author
- Ma, Shao-Gang
- Venue
- Cancer Biomarkers
- Publisher
- SAGE Publications
- Published
- 2015-11-24
- Volume
- 15
- Issue
- 6
- Pages
- 909-913
- ISSN
- 1574-0153 (ISSN-L)
- 1875-8592
- PMC
- PMC12965488
- OpenAlex
- W2236653459
- Cited by
- 16
- References
- 15
- Citations by year
- 2026: 2 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 1 · 2019: 1 · 2017: 1
- FWCI
- 0.29
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Locations
- Cancer Biomarkers (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Government of Jiangsu Province
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Head and Neck Anomalies
- Keywords
- thyroid peroxidase, papillary thyroid carcinoma, compound heterozygosity, congenital goiter, hypothyroidism, familial thyroid cancer, fine-needle aspiration, BRAF V600E mutation
- MeSH terms
- Adult, Aged, Autoantigens, Carcinoma, Papillary, Congenital Hypothyroidism, Female, Humans, Iodide Peroxidase, Male, Mutation, Prognosis, Thyroid Neoplasms, Thyroid Nodule, Iron-Binding Proteins, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.